Financhill
Buy
68

UTG Quote, Financials, Valuation and Earnings

Last price:
$32.12
Seasonality move :
0.27%
Day range:
$31.81 - $32.50
52-week range:
$25.26 - $35.29
Dividend yield:
1.85%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
292.4K
Avg. volume:
278.5K
1-year change:
18.15%
Market cap:
--
Revenue:
-$69.9M
EPS (TTM):
--
Period Ending 2019-10-31 2020-10-31 2021-10-31 2022-10-31 2023-10-31
Revenue $341.3M -$172.7M $256.8M -$214.5M -$69.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6.1M $6.1M $7M $7.5M $4.5M
Other Inc / (Exp) $73.2M $59M $87M $134.4M $121.7M
Operating Expenses $7.2M $6.1M $7M $7.5M $4.5M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $334.1M -$178.9M $249.8M -$222M -$74.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $334.1M -$178.9M $249.8M -$222M -$74.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $334.1M -$178.9M $249.8M -$222M -$74.4M
 
Basic EPS (Cont. Ops) $6.86 -$3.59 $4.52 -$3.10 -$0.90
Diluted EPS (Cont. Ops) $6.86 -$3.59 $4.52 -$3.10 -$0.90
Weighted Average Basic Share $48.7M $49.8M $55.3M $71.6M $82.6M
Weighted Average Diluted Share $48.7M $49.8M $55.3M $71.6M $82.6M
 
EBITDA -- -- -- -- --
EBIT $348.8M -$172.2M $253.4M -$213.5M -$45.9M
 
Revenue (Reported) $341.3M -$172.7M $256.8M -$214.5M -$69.9M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $348.8M -$172.2M $253.4M -$213.5M -$45.9M
Period Ending 2021-01-11 2022-01-11 2023-01-11 2024-01-11
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2021-01-11 2022-01-11 2023-01-11 2024-01-11
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-01-11 2021-01-11 2022-01-11 2023-01-11 2024-01-11
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2019-10-31 2020-10-31 2021-10-31 2022-10-31 2023-10-31
Cash and Equivalents -- -- $1.4M $625.8K $994.5K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- $103.5K $22K
Other Current Assets -- -- -- -- --
Total Current Assets $3.1M $6.3M $9M $6.2M $5.7M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments $2.2B $2B $2.6B $2.5B $2.4B
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $2.2B $2B $2.6B $2.5B $2.4B
 
Accounts Payable $1.1M $6.8M $5.6M $1.5M $10M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.1M $6.9M $5.6M $3M $11.5M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $448M $353.6M $458.4M $503.1M $531.5M
 
Common Stock $1.1B $1.3B $1.7B $1.9B $2B
Other Common Equity Adj -- -- -- -- --
Common Equity $1.8B $1.7B $2.2B $2B $1.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $1.8B $1.7B $2.2B $2B $1.9B
 
Total Liabilities and Equity $2.2B $2B $2.6B $2.5B $2.4B
Cash and Short Terms -- -- $1.4M $625.8K $994.5K
Total Debt -- -- -- -- --
Period Ending 2020-04-30 2021-04-30 2022-04-30 2023-04-30 2024-04-30
Cash and Equivalents -- $1.6M -- $910.7K $699.8K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- $53.3K $11.5K
Other Current Assets -- -- -- -- --
Total Current Assets $3.4M $5.8M $2.3M $15.3M $12.4M
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments $1.9B $2.4B $2.7B $2.7B $2.7B
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $1.9B $2.4B $2.7B $2.7B $2.7B
 
Accounts Payable $176.9K $14.4M $7.4M $7.3M $10.9M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $176.9K $14.4M $7.4M $8.9M $12.5M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $446.7M $411.3M $460.3M $529.1M $557.6M
 
Common Stock $1.2B $1.4B $1.8B $2B $2.2B
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $1.4B $2B $2.3B $2.2B $2.1B
 
Total Liabilities and Equity $1.9B $2.4B $2.7B $2.7B $2.7B
Cash and Short Terms -- $1.6M -- $910.7K $699.8K
Total Debt -- -- -- -- --
Period Ending 2019-10-31 2020-10-31 2021-10-31 2022-10-31 2023-10-31
Net Income to Stockholders $334.1M -$178.9M $249.8M -$222M -$74.4M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $145.2K $685.4K -$539.2K $30.8K -$1.3M
Change in Inventories -- -- -- -- --
Cash From Operations $99.1M $45.5M -$351.3M -$111.4M $4.8M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -$99M -$104.8M -$124.9M -$151.7M -$162.4M
Special Dividend Paid
Long-Term Debt Issued -- $74K $105M $50M $20M
Long-Term Debt Repaid -- -$100M -$74K -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$99M -$45.6M $352.7M $110.7M -$4.5M
 
Beginning Cash (CF) $40.1K $96.8K -- $1.4M $625.8K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $56.7K -$96.8K $1.4M -$736.5K $368.7K
Ending Cash (CF) $96.8K -- $1.4M $625.8K $994.5K
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-01-11 2022-01-11 2023-01-11 2024-01-11
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-01-11 2022-01-11 2023-01-11 2024-01-11
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-01-11 2021-01-11 2022-01-11 2023-01-11 2024-01-11
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Why Is Marvell Stock Up?
Why Is Marvell Stock Up?

Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
44
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
1
IONQ alert for Jan 10

IonQ [IONQ] is up 7.07% over the past day.

Sell
47
CEG alert for Jan 10

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
8
CRNX alert for Jan 10

Crinetics Pharmaceuticals [CRNX] is down 16.31% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock